JP5717356B2 - Oil composition containing vitamin B1 - Google Patents

Oil composition containing vitamin B1 Download PDF

Info

Publication number
JP5717356B2
JP5717356B2 JP2010113906A JP2010113906A JP5717356B2 JP 5717356 B2 JP5717356 B2 JP 5717356B2 JP 2010113906 A JP2010113906 A JP 2010113906A JP 2010113906 A JP2010113906 A JP 2010113906A JP 5717356 B2 JP5717356 B2 JP 5717356B2
Authority
JP
Japan
Prior art keywords
oil
vitamin
fat
derivative
oils
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010113906A
Other languages
Japanese (ja)
Other versions
JP2011239714A (en
Inventor
清水 将夫
将夫 清水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2010113906A priority Critical patent/JP5717356B2/en
Application filed by Kao Corp filed Critical Kao Corp
Priority to EP11765975.5A priority patent/EP2556751B1/en
Priority to CN201180018043.7A priority patent/CN102834019B/en
Priority to BR112012025757-9A priority patent/BR112012025757B1/en
Priority to KR1020127025948A priority patent/KR101830450B1/en
Priority to US13/639,930 priority patent/US20130040968A1/en
Priority to PCT/JP2011/058817 priority patent/WO2011126075A1/en
Priority to RU2012147462/13A priority patent/RU2550024C2/en
Priority to MYPI2012004471A priority patent/MY158524A/en
Priority to TW100112313A priority patent/TWI532434B/en
Publication of JP2011239714A publication Critical patent/JP2011239714A/en
Application granted granted Critical
Publication of JP5717356B2 publication Critical patent/JP5717356B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明は、ビタミンB1含有油脂組成物に関する。   The present invention relates to a vitamin B1-containing oil and fat composition.

油脂は、タンパク質、糖質とともに重要な栄養素で、特にエネルギー源として有用である。また、油脂は調理上、熱媒体等としても用いられている。また、油脂そのもののもつ良好な風味を付与する重要な素材である。近年の健康指向を背景に、食用油に栄養成分を強化して商品の訴求力を上げる試みがなされており、例えば、生理活性が高いα−、β−トコフェロールを高い含有量で含む安定化トコフェロール含有油脂組成物(特許文献1)等が報告されている。
前記トコフェロールは、脂溶性ビタミンであるビタミンEの一種で、もともと油脂に天然成分として含まれている成分である。しかし、栄養成分の中には油に不溶のものも多く、本来強化したい量を加えられないものが多い。
Oils and fats are important nutrients along with proteins and carbohydrates, and are particularly useful as energy sources. In addition, fats and oils are used as a heat medium for cooking. In addition, it is an important material that imparts a good flavor of the oil itself. Against the background of health orientation in recent years, attempts have been made to enhance the appeal of products by strengthening nutritional components in edible oils, for example, stabilized tocopherol containing α-, β-tocopherol with high physiological activity at a high content An oil-and-fat composition (Patent Document 1) and the like have been reported.
The tocopherol is a kind of vitamin E, which is a fat-soluble vitamin, and is a component originally contained in fats and oils as a natural component. However, many of the nutritional components are insoluble in oil, and many of them cannot add the amount that they originally want to strengthen.

一方、ビタミンB1は、糖質の代謝、神経機能正常化等に関与する水溶性ビタミンの一つで、ヒトの健康維持にとって適量のビタミンB1を摂取することは重要であるが、特に、欠食率の増加や加工食品への依存等が原因で不足しがちである。ビタミンB1を栄養素強化食品で補う場合、「第6次改定日本人の栄養所要量」を基準に1日の所要量の1/3以上摂取できるのが望ましい。   On the other hand, vitamin B1 is one of the water-soluble vitamins involved in carbohydrate metabolism, normalization of nerve function, etc., and it is important to take an appropriate amount of vitamin B1 for maintaining human health. It tends to be deficient due to the increase in food consumption and dependence on processed foods. When supplementing vitamin B1 with a nutrient-enriched food, it is desirable to be able to take 1/3 or more of the daily requirement based on the “6th revised Japanese nutritional requirement”.

特開平8−173035号公報JP-A-8-173035

ビタミンB1は溶解性が低く、また独特な苦味を呈するため、その配合量は制限されざるを得ず、また、配合することにより食品等の風味が低下するという問題がある。本発明者は、従来から使用され、トリアシルグリセロールを主な構成成分とする食用油にビタミンB1誘導体を溶解させようと試みたが、十分な量を溶解させられないことがわかった。
従って、本発明の課題は、苦味が少なく、ビタミンB1を高濃度溶解する油脂組成物を提供することにある。
Since vitamin B1 has low solubility and exhibits a unique bitter taste, the blending amount thereof must be limited, and there is a problem that the flavor of foods and the like is lowered by blending. The present inventor tried to dissolve the vitamin B1 derivative in an edible oil that has been used in the past and contains triacylglycerol as a main component, but it has been found that a sufficient amount cannot be dissolved.
Therefore, the subject of this invention is providing the oil-fat composition which has few bitter tastes and melt | dissolves vitamin B1 with high concentration.

本発明者は、鋭意検討を重ねた結果、油脂組成物の水酸基価(OHV)が一定以上で、かつビタミンB1誘導体の含有量と該水酸基価の値とが一定の関係を満たす場合に、ビタミンB1誘導体を高濃度溶解させることができること、さらにビタミンB1誘導体濃度が高いにもかかわらず苦味が低減することを見出した。   As a result of intensive studies, the inventor has found that when the hydroxyl value (OHV) of the oil and fat composition is not less than a certain value and the content of the vitamin B1 derivative and the value of the hydroxyl value satisfy a certain relationship, the vitamin It has been found that the B1 derivative can be dissolved at a high concentration, and that the bitterness is reduced despite the high vitamin B1 derivative concentration.

すなわち、本発明は、ビタミンB1誘導体又はその塩をチアミン換算で44〜8,000ppm含有し、水酸基価が9〜100mg−KOH/gである油脂組成物であって、ビタミンB1誘導体又はその塩のチアミン換算における含有量C(ppm)と水酸基価X(mg−KOH/g)が次式(1)の関係を満たす油脂組成物を提供するものである。
(数1)
[Ln(C/143)]/X≦0.044 (Ln:自然対数) (1)
That is, the present invention is an oil and fat composition containing a vitamin B1 derivative or a salt thereof in an amount of 44 to 8,000 ppm in terms of thiamine and having a hydroxyl value of 9 to 100 mg-KOH / g, the vitamin B1 derivative or a salt thereof The oil and fat composition in which the content C (ppm) in terms of thiamine and the hydroxyl value X (mg-KOH / g) satisfy the relationship of the following formula (1) is provided.
(Equation 1)
[Ln (C / 143)] / X ≦ 0.044 (Ln: natural logarithm) (1)

本発明によれば、苦味が少なく、高濃度のビタミンB1を溶解して含有する油脂組成物を提供することができる。   According to the present invention, it is possible to provide an oil and fat composition that has little bitter taste and contains a high concentration of vitamin B1 dissolved therein.

本発明における油脂組成物は、水酸基価(OHV)が9〜100mg−KOH/gであるが、特に20〜100mg−KOH/g、殊更40〜100mg−KOH/gであるのが、ビタミンB1の溶解性向上及び苦味抑制の点から好ましい。
ここで、水酸基価は日本油化学会編「基準油脂分析試験法2003年版」中の「ヒドロキシル価(ピリジン−無水酢酸法 2.3.6.2−1996)」により測定した値をいう。
水酸基価の測定方法の詳細は実施例に記載した。
The oil and fat composition of the present invention has a hydroxyl value (OHV) of 9 to 100 mg-KOH / g, particularly 20 to 100 mg-KOH / g, more preferably 40 to 100 mg-KOH / g. It is preferable from the viewpoint of improving solubility and suppressing bitterness.
Here, the hydroxyl value is a value measured by “hydroxyl number (pyridine-acetic anhydride method 2.3.6.2-1996)” in “Standard Oil Analysis Test Method 2003 Edition” edited by Japan Oil Chemists' Society.
Details of the method for measuring the hydroxyl value are described in Examples.

本発明の水酸基価(OHV)が9〜100mg−KOH/g以上である油脂組成物は、水酸基価が前記範囲になるように油脂や乳化剤などを単独、または適宜組み合わせて調製できるが、モノアシルグリセロール及び/又はジアシルグリセロールの含有割合の高いものを使用するのが好ましい。
なお、本発明において「油脂」とは、トリアシルグリセロール、ジアシルグリセロール、モノアシルグリセロールのいずれか1種以上を含むものとする。
本発明の油脂組成物中、ジアシルグリセロールの含有量は10質量%(以下、単に「%」とする)以上が好ましく、更に20%以上、特に40%以上であるのが、ビタミンB1の溶解性向上及び苦味抑制の点から好ましい。上限は特に規定されないが、99%以下が好ましく、98%以下がより好ましく、97%以下が更に好ましい。
また、モノアシルグリセロールの含有量は、0〜5%が好ましく、更に0〜2%、特に0.1〜2%であるのが、ビタミンB1の溶解性向上及び苦味抑制の点、食用油としての風味の点、工業生産性の点から好ましい。
The oil and fat composition having a hydroxyl value (OHV) of 9 to 100 mg-KOH / g or more according to the present invention can be prepared by combining oils and emulsifiers alone or in an appropriate combination so that the hydroxyl value is in the above range. It is preferable to use one having a high content of glycerol and / or diacylglycerol.
In the present invention, “oil / fat” includes one or more of triacylglycerol, diacylglycerol, and monoacylglycerol.
In the oil and fat composition of the present invention, the content of diacylglycerol is preferably 10% by mass (hereinafter simply referred to as “%”) or more, more preferably 20% or more, particularly 40% or more. It is preferable from the point of improvement and bitterness suppression. The upper limit is not particularly defined, but is preferably 99% or less, more preferably 98% or less, and still more preferably 97% or less.
In addition, the content of monoacylglycerol is preferably 0 to 5%, more preferably 0 to 2%, particularly 0.1 to 2%, in terms of improving the solubility of vitamin B1 and suppressing bitterness, as an edible oil From the viewpoint of flavor and industrial productivity, it is preferable.

本発明の油脂組成物中の油脂は、植物性油脂、動物性油脂のいずれを原料とするものでもよい。具体的な原料としては、例えば、大豆油、ナタネ油、サフラワー油、米糠油、コーン油、パーム油、ヒマワリ油、綿実油、オリーブ油、ゴマ油、シソ油等の植物性油脂、更に魚油、ラード、牛脂、バター脂等の動物性油脂、あるいはそれらのエステル交換油、水素添加油、分別油等の油脂類を挙げることができるが、水素添加していないものであることが、食用油脂を構成する全脂肪酸中のトランス不飽和脂肪酸含量を低減させる点から好ましい。   The fats and oils in the fat and oil composition of the present invention may be made from either vegetable oils or animal fats. Specific raw materials include, for example, vegetable oils such as soybean oil, rapeseed oil, safflower oil, rice bran oil, corn oil, palm oil, sunflower oil, cottonseed oil, olive oil, sesame oil, perilla oil, fish oil, lard, Animal fats and oils such as beef tallow and butter fats, or fats and oils such as transesterified oils, hydrogenated oils and fractionated oils can be mentioned, but those that are not hydrogenated constitute edible fats and oils This is preferable from the viewpoint of reducing the content of trans-unsaturated fatty acids in the total fatty acids.

本発明の油脂組成物中の油脂を構成する脂肪酸は、特に限定されず、飽和脂肪酸又は不飽和脂肪酸のいずれであってもよいが、40〜100%が不飽和脂肪酸であることが好ましく、より好ましくは80〜100%、さらに90〜100%であるのが外観、油脂の工業的生産性の点で好ましい。不飽和脂肪酸の炭素数は14〜24、さらに16〜22であるのが生理効果の点から好ましい。   Fatty acids constituting the fats and oils in the fat and oil composition of the present invention are not particularly limited, and may be either saturated fatty acids or unsaturated fatty acids, but 40 to 100% are preferably unsaturated fatty acids, more It is preferably 80 to 100%, more preferably 90 to 100% from the viewpoint of appearance and industrial productivity of fats and oils. The number of carbon atoms of the unsaturated fatty acid is preferably 14 to 24, and more preferably 16 to 22 from the viewpoint of physiological effects.

また、油脂組成物中の油脂を構成する脂肪酸のうち、飽和脂肪酸の含有量は60%未満であることが好ましく、より好ましくは0〜20%、さらに0〜10%であるのが、外観、生理効果、油脂の工業的生産性の点で好ましい。飽和脂肪酸としては、炭素数14〜24、特に16〜22のものが好ましい。   Moreover, it is preferable that content of a saturated fatty acid is less than 60% among the fatty acids which comprise the fats and oils in an oil-fat composition, More preferably, it is 0-20%, Furthermore, it is 0-10%, an external appearance, It is preferable in terms of physiological effects and industrial productivity of fats and oils. The saturated fatty acid is preferably those having 14 to 24 carbon atoms, particularly 16 to 22 carbon atoms.

油脂組成物中の油脂を構成する脂肪酸のうち、トランス不飽和脂肪酸の含有量は、0〜4%、好ましくは0.1〜3.5%、さらに0.2〜3%であるのが風味、生理効果、外観、油脂の工業的生産性の点で好ましい。   Of the fatty acids constituting the fats and oils in the fat and oil composition, the content of trans-unsaturated fatty acids is 0 to 4%, preferably 0.1 to 3.5%, and more preferably 0.2 to 3%. From the viewpoint of physiological effect, appearance, and industrial productivity of fats and oils.

本発明の油脂組成物に用いられる添加される乳化剤としては、モノアシルグリセロール、ジアシルグリセロールの他、ポリグリセリン縮合リシノレイン酸エステル、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル等のポリオール脂肪酸エステルなどが挙げられる。   Examples of the emulsifier to be added to the oil and fat composition of the present invention include monoacylglycerol, diacylglycerol, polyglycerin condensed ricinoleic acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan Examples include polyol fatty acid esters such as fatty acid esters and propylene glycol fatty acid esters.

本発明における油脂組成物は、ビタミンB1誘導体又はその塩をチアミン換算で44〜8,000ppm含有するものであるが、その含有量はさらに44〜5,000ppm、特に44〜3,000ppm、より好ましくは150〜3,000ppmであることが安定性、生理効果の点から好ましい。油脂組成物におけるビタミンB1誘導体の含有量は、実施例に記載の方法で測定できる。   The oil and fat composition in the present invention contains 44 to 8,000 ppm of vitamin B1 derivative or a salt thereof in terms of thiamine, and the content thereof is further 44 to 5,000 ppm, particularly 44 to 3,000 ppm, more preferably. Is preferably from 150 to 3,000 ppm from the viewpoint of stability and physiological effects. The content of the vitamin B1 derivative in the oil / fat composition can be measured by the method described in Examples.

本発明におけるビタミンB1誘導体又はその塩としては、例えば、ビスベンチアミンジスルフィド、ベンフォチアミン、フルスルチアミン、オクトチアミン、ジベンゾイルチアミン、シコチアミン、スルブチアミン、アセチアミン、ジセチアミン、又はそれらの塩が挙げられる。塩としては、薬学的に許容される塩であればよく、例えば硝酸塩、塩酸塩、硫酸塩等の鉱酸塩;酢酸塩、プロピオン酸塩、酒石酸塩、フマル酸塩、マレイン酸塩、リンゴ酸塩、クエン酸塩、メタンスルホン酸塩、p-トルエンスルホン酸塩、トリフルオロ酢酸塩等の有機酸塩が挙げられる。これらは1種又は2種以上を適宜選択して使用できる。なかでも、ビタミンB1誘導体、特にビスベンチアミンジスルフィドが溶解性、生理効果の点で好ましい。
ビタミンB1誘導体又はその塩は公知の化合物であり、その入手方法としては、市販品を用いてもよく、また公知の方法に基づき製造することも可能である。
Examples of the vitamin B1 derivative or salt thereof in the present invention include bisbenchamine disulfide, benfotiamine, fursultiamine, octothiamine, dibenzoylthiamine, chicotiamine, sulbutiamine, acetylamine, dicetiamine, or salts thereof. The salt may be a pharmaceutically acceptable salt, for example, a mineral salt such as nitrate, hydrochloride, sulfate, etc .; acetate, propionate, tartrate, fumarate, maleate, malic acid Organic salts such as salt, citrate, methanesulfonate, p-toluenesulfonate, trifluoroacetate and the like can be mentioned. These can be used by appropriately selecting one or two or more. Of these, vitamin B1 derivatives, particularly bisbenchamine disulfide, are preferred in terms of solubility and physiological effects.
The vitamin B1 derivative or a salt thereof is a known compound, and as a method for obtaining the vitamin B1 derivative, a commercially available product may be used, or it can be produced based on a known method.

本発明における油脂組成物は、ビタミンB1誘導体又はその塩のチアミン換算における含有量C(ppm)と水酸基価X(mg−KOH/g)とが、下記(1)式の関係を満たす。
[Ln(C/143)]/X≦0.044 (Ln:自然対数) (1)
Ln:自然対数
In the oil and fat composition of the present invention, the content C (ppm) of the vitamin B1 derivative or its salt in terms of thiamine and the hydroxyl value X (mg-KOH / g) satisfy the relationship of the following formula (1).
[Ln (C / 143)] / X ≦ 0.044 (Ln: natural logarithm) (1)
Ln: natural logarithm

さらに、ビタミンB1誘導体又はその塩のチアミン換算における含有量C(ppm)と水酸基価X(mg−KOH/g)とが下記(2)式を満たすことで、ビタミンB1誘導体由来の苦味をさらに抑制することができることを本発明者は見出した。
[Ln(C/82)]/X≦0.04 (2)
Ln:上記と同じ
Furthermore, when the content C (ppm) of the vitamin B1 derivative or its salt in terms of thiamine and the hydroxyl value X (mg-KOH / g) satisfy the following formula (2), the bitterness derived from the vitamin B1 derivative is further suppressed. The inventor has found that this can be done.
[Ln (C / 82)] / X ≦ 0.04 (2)
Ln: Same as above

すなわち、本発明においては、油脂組成物の水酸基価により溶解するビタミンB1誘導体の量が変化する。具体的には、ビタミンB1誘導体又はその塩のチアミン換算における含有量Cが44ppm以上8,000ppm以下の場合は、油脂組成物の水酸基価は9mg−KOH/g以上100mg−KOH/g以下であるが、該含有量Cが500ppm以上8,000ppm以下の場合は、ビタミンB1の溶解性向上及び苦味抑制の点から、水酸基価は30mg−KOH/g以上であることが好ましく、50mg−KOH/g以上であることがさらに好ましい。
また、該含有量Cが1,000ppm以上8,000ppm以下の場合は、同様の点から水酸基価は50mg−KOH/g以上であることが好ましく、66mg−KOH/g以上であることがさらに好ましい。該含有量Cが1,500ppm以上8,000ppm以下の場合は、同様の点から水酸基価は60mg−KOH/g以上であることが好ましく、76mg−KOH/g以上であることがさらに好ましい。
That is, in the present invention, the amount of the vitamin B1 derivative that is dissolved varies depending on the hydroxyl value of the oil and fat composition. Specifically, when the content C of the vitamin B1 derivative or a salt thereof in terms of thiamine is 44 ppm or more and 8,000 ppm or less, the hydroxyl value of the oil or fat composition is 9 mg-KOH / g or more and 100 mg-KOH / g or less. However, when the content C is 500 ppm or more and 8,000 ppm or less, the hydroxyl value is preferably 30 mg-KOH / g or more and 50 mg-KOH / g from the viewpoint of improving the solubility of vitamin B1 and suppressing the bitterness. More preferably, it is the above.
When the content C is 1,000 ppm or more and 8,000 ppm or less, the hydroxyl value is preferably 50 mg-KOH / g or more, more preferably 66 mg-KOH / g or more from the same point. . When the content C is 1,500 ppm or more and 8,000 ppm or less, the hydroxyl value is preferably 60 mg-KOH / g or more, more preferably 76 mg-KOH / g or more from the same point.

本発明の油脂組成物は、さらにビタミンCもしくはその誘導体、又はニコチン酸アミドを溶解して含有することができる。ビタミンCもしくはその誘導体としては、アスコルビン酸、アスコルビン酸パルミチン酸エステル、アスコルビン酸ステアリン酸エステル等が挙げられる。ニコチン酸アミドは、ビタミンB群に属するナイアシンの一種である。
油脂組成物におけるビタミンCもしくはその誘導体の含有量は、アスコルビン酸換算で420〜8,400ppmが好ましく、特に2,100〜8,400ppmが好ましい。また、ニコチン酸アミドの含有量は、1,000〜20,000ppmが好ましく、特に1,000〜6,000ppmが好ましい。
The oil and fat composition of the present invention can further contain vitamin C or a derivative thereof, or nicotinamide, dissolved therein. Examples of vitamin C or derivatives thereof include ascorbic acid, ascorbyl palmitate, ascorbate stearate, and the like. Nicotinamide is a kind of niacin belonging to the vitamin B group.
The content of vitamin C or a derivative thereof in the oil and fat composition is preferably 420 to 8,400 ppm, particularly 2,100 to 8,400 ppm in terms of ascorbic acid. Further, the content of nicotinic acid amide is preferably 1,000 to 20,000 ppm, particularly preferably 1,000 to 6,000 ppm.

本発明の油脂組成物には、更に一般の食用油脂と同様に、保存性及び風味安定性の向上の観点から、抗酸化剤を添加することができる。抗酸化剤としては、天然抗酸化剤、トコフェロール、BHT、BHA、リン脂質、有機カルボン酸、ポリフェノール等が挙げられる。   An antioxidant may be added to the oil and fat composition of the present invention from the viewpoint of improving the storage stability and flavor stability, as in the case of general edible oils and fats. Antioxidants include natural antioxidants, tocopherols, BHT, BHA, phospholipids, organic carboxylic acids, polyphenols and the like.

本発明の油脂組成物中の水分量は、15,000ppm以下であるのが好ましく、更に10,000ppm以下、特に3,000ppm以下であるのが、保存安定性及び加熱調理時の使用性の点から好ましい。   The water content in the oil and fat composition of the present invention is preferably 15,000 ppm or less, more preferably 10,000 ppm or less, particularly 3,000 ppm or less, in terms of storage stability and usability during cooking. To preferred.

本発明の油脂組成物は、一般の食用油脂と同様に使用でき、また各種飲食品、飼料及び医薬品に利用することもできる。飲食品としては、例えば、ドリンク、デザート、アイスクリーム、ドレッシング、トッピング、マヨネーズ、焼肉のたれ等の水中油型油脂加工食品;マーガリン、スプレッド等の油中水型油脂加工食品;ピーナッツバター、フライングショートニング、ベーキングショートニング等の加工油脂食品;ポテトチップ、スナック菓子、ケーキ、クッキー、パイ、パン、チョコレート等の加工食品;ベーカリーミックス;加工肉製品;冷凍アントレ;冷凍食品等が挙げられる。   The oil and fat composition of the present invention can be used in the same manner as general edible oils and fats, and can also be used for various foods and drinks, feeds and pharmaceuticals. Food / beverage products include, for example, drinks, desserts, ice creams, dressings, toppings, mayonnaise, roasted meat and other oil-in-water processed foods; margarine, spreads and other water-in-oil processed oils; peanut butter Processed fats and oils such as baking shortenings; processed foods such as potato chips, snacks, cakes, cookies, pies, breads, chocolates; bakery mixes; processed meat products; frozen entrées;

〔分析方法〕
(i)グリセリド組成
ガラス製サンプル瓶に、油脂サンプル約10mgとトリメチルシリル化剤(「シリル化剤TH」、関東化学製)0.5mLを加え、密栓し、70℃で15分間加熱した。これに水1.0mLとヘキサン1.5mLを加え、振とうした。静置後、上層をガスクロマトグラフィー(GLC)に供して分析した。
[Analysis method]
(i) Glyceride composition About 10 mg of an oil and fat sample and 0.5 mL of a trimethylsilylating agent (“silylating agent TH”, manufactured by Kanto Chemical) were added to a glass sample bottle, sealed, and heated at 70 ° C. for 15 minutes. To this, 1.0 mL of water and 1.5 mL of hexane were added and shaken. After standing, the upper layer was analyzed by gas chromatography (GLC).

(ii)脂肪酸組成
日本油化学会編「基準油脂分析試験法」中の「脂肪酸メチルエステルの調製法(2.4.1.−1996)」に従って脂肪酸メチルエステルを調製し、得られたサンプルを、American Oil Chemists.Society Official Method Ce 1f−96(GLC法)により測定した。
(ii) Fatty acid composition Fatty acid methyl ester was prepared according to “Fatty acid methyl ester preparation method (2.4.1.-1996)” in “Standard oil analysis test method” edited by Japan Oil Chemists' Society. , American Oil Chemists. It was measured by Society Official Method Ce 1f-96 (GLC method).

(iii)水酸基価
日本油化学会編「基準油脂分析試験法」中の「ヒドロキシル価(ピリジン−無水酢酸法 2.3.6.2−1996)」に従い、首長の丸底フラスコに油脂サンプル約5gを計量し、アセチル化試薬5mlを加え、フラスコの首に小さな漏斗をのせ、フラスコの底部を加熱浴に約1cmの深さに沈めて95〜100℃に加熱した。1時間後、加熱浴からフラスコを取り出し冷却し、漏斗から1mlの蒸留水を加え、再度加熱浴に入れ10分間加熱した。再び常温まで冷却し、漏斗やフラスコの首に凝縮した液を5mlの中性エタノールでフラスコ内に洗い流し、0.5mol/L水酸化カリウム−エタノール標準液でフェノールフタレイン指示薬を用いて滴定した。なお、本試験と並行して空試験を行い、滴定結果から下記の式をもとに算出した値を「水酸基価(mg−KOH/g)」(OHV)とした。
水酸基価=(A−B)×28.05×F/C+酸価
(A:空試験の0.5mol/L水酸化カリウム−エタノール標準液使用量(ml)、B:本試験の0.5mol/L水酸化カリウム−エタノール標準液使用量(ml)、F:0.5mol/L水酸化カリウム−エタノール標準液のファクター、C:試料採取量(g))
(iii) Hydroxyl value In accordance with “Hydroxyl number (pyridine-acetic anhydride method 2.3.6.2-1996)” in “Standard Analysis Method for Fats and Oils” edited by the Japan Oil Chemists' Society, a sample of fats and oils was placed in a round-bottom flask on the neck. 5 g was weighed, 5 ml of acetylating reagent was added, a small funnel was placed on the neck of the flask, and the bottom of the flask was submerged in a heating bath to a depth of about 1 cm and heated to 95-100 ° C. After 1 hour, the flask was taken out of the heating bath, cooled, 1 ml of distilled water was added from the funnel, and again placed in the heating bath and heated for 10 minutes. The solution was cooled again to room temperature, and the liquid condensed on the funnel and the neck of the flask was washed into the flask with 5 ml of neutral ethanol and titrated with a 0.5 mol / L potassium hydroxide-ethanol standard solution using a phenolphthalein indicator. In addition, the blank test was performed in parallel with this test, and the value calculated from the titration result based on the following formula was defined as “hydroxyl value (mg-KOH / g)” (OHV).
Hydroxyl value = (A−B) × 28.05 × F / C + acid number (A: 0.5 mol / L potassium hydroxide-ethanol standard solution used in blank test (ml), B: 0.5 mol of this test) / L potassium hydroxide-ethanol standard solution usage (ml), F: factor of 0.5 mol / L potassium hydroxide-ethanol standard solution, C: sampling amount (g))

(iv)ビスベンチアミンジスルフィドの定量
油脂サンプル0.5gに、ツィーン80を0.3g、酢酸緩衝液5ml、10%チオ尿素溶液1mlを添加し、pHを4.5に調整した。
2.5%−タカジアスターゼ溶液を3ml添加し、40度で一晩おいた。2Nの塩酸5mlとエタノール70mlを添加し、70℃で30分間、時々かき混ぜながら処理した。蒸留水で100mlに定容後ろ過したものを抽出液とした。抽出液5mlに0.7%−システイン溶液を1ml、4N−水酸化ナトリウム溶液を1ml添加し、室温で30分反応させた後、4N−塩酸1mlを添加し蒸留水で20mlに定容したものをHPLCに供した。
HPLC条件:
カラム:ODS−3(4.6ID×250mm), GLサイエンス製
カラム温度:40℃
移動相:(0.01mol−りん酸2水素ナトリウム+0.15mol/L−過塩素酸ナトリウム)混合溶液(pH2.2):メタノール=95:5
移動相流量:1ml/min
注入量:20μl
検出:蛍光検出器Ex=375nm,Em=440nm
反応液:0.05%フェリシアン化カリウム+15%−水酸化ナトリウム
反応液流量:0.4ml/min
(Iv) Quantification of bisbenchamine disulfide 0.3 g of Tween 80, 5 ml of acetic acid buffer solution and 1 ml of 10% thiourea solution were added to 0.5 g of an oil and fat sample to adjust the pH to 4.5.
3 ml of 2.5% -Takadiastase solution was added and left overnight at 40 degrees. 5 ml of 2N hydrochloric acid and 70 ml of ethanol were added and treated at 70 ° C. for 30 minutes with occasional stirring. The extract was adjusted to a volume of 100 ml with distilled water and filtered. 1 ml of 0.7% -cysteine solution was added to 5 ml of the extract, and 1 ml of 4N-sodium hydroxide solution was added and reacted at room temperature for 30 minutes, and then 1 ml of 4N-hydrochloric acid was added and the volume was adjusted to 20 ml with distilled water Was subjected to HPLC.
HPLC conditions:
Column: ODS-3 (4.6 ID × 250 mm), GL Sciences column temperature: 40 ° C.
Mobile phase: (0.01 mol-sodium dihydrogen phosphate + 0.15 mol / L-sodium perchlorate) mixed solution (pH 2.2): methanol = 95: 5
Mobile phase flow rate: 1 ml / min
Injection volume: 20 μl
Detection: Fluorescence detector Ex = 375 nm, Em = 440 nm
Reaction solution: 0.05% potassium ferricyanide + 15% -sodium hydroxide Reaction solution flow rate: 0.4 ml / min

(v)ニコチン酸アミドの定量
油脂サンプル1gにメタノール2mlを加えボルテックスミキサーでよく攪拌し、分相後、メタノール相採取した。残留液にメタノール2mlを加えて同様に抽出した。合わせてメタノールで3回の抽出操作を行い、メタノール相を合わせて室温窒素気流下で乾燥させた。アセトニトリル1mlに転溶後、ヘキサン1mlで3度洗浄した。洗浄後のアセトニトリル相を室温窒素気流下で乾燥させ、再度、アセトニトリルに溶解・定容し、HPLCに供した。
HPLC条件:
カラム:ODS−3(4.6ID×250mm), GLサイエンス製
カラム温度:40℃
移動相:0.05N−りん酸二水素ナトリウム(A)/メタノール(B)の混合溶媒
グラジエント:A/B=95/5(0min)→A/B=5/95(50min)
移動相流量:0.5ml/min
注入量:20μl
検出:UV検出器260nm
(V) Determination of nicotinic acid amide 2 g of methanol was added to 1 g of an oil and fat sample, and the mixture was well stirred with a vortex mixer. To the residual liquid, 2 ml of methanol was added and extracted in the same manner. The extraction operation was performed three times with methanol, and the methanol phases were combined and dried under a nitrogen stream at room temperature. After dissolving in 1 ml of acetonitrile, it was washed 3 times with 1 ml of hexane. The acetonitrile phase after washing was dried at room temperature under a nitrogen stream, dissolved and fixed in acetonitrile again, and subjected to HPLC.
HPLC conditions:
Column: ODS-3 (4.6 ID × 250 mm), GL Sciences column temperature: 40 ° C.
Mobile phase: 0.05N-mixed solvent gradient of sodium dihydrogen phosphate (A) / methanol (B): A / B = 95/5 (0 min) → A / B = 5/95 (50 min)
Mobile phase flow rate: 0.5 ml / min
Injection volume: 20 μl
Detection: UV detector 260 nm

(vi)アスコルビン酸パルミテートの定量
油脂サンプル5gにアスコルビン酸0.5gと80%-エタノールを20ml添加し、ボルテックスミキサーにより攪拌した。静置分離後、エタノール層を採取し、残留物に80%-エタノールを10ml添加して同様の操作を行い、エタノール層を採取した。残留物に再度、80%-エタノールを10ml添加し、同様の操作を行った。得られたエタノール層を合算して、0.05N-酢酸緩衝液(pH4)(緩衝液A)にて50mlに定容し、グラスフィルターにてろ過した。ろ液2mlを、予めメタノール10mlと緩衝液(A)5mlで処理した固相抽出カラム(Sep-Pak C18)に負荷し、蒸留水10ml、緩衝液A:エタノール=1:1の混合溶液5mlで洗浄した後、メタノール4mlで溶出させた。溶出液に1%ホモシステイン水溶液を0.2ml添加し、40度で15分間の処理の後、1%-アスコルビン酸水溶液にて10mlに定容しHPLCに供した。
HPLCの条件:
カラム:ODS−3(4.6ID×250mm), GLサイエンス製
カラム温度:40℃
移動相:メタノール/0.05M酢酸緩衝液(pH6.5)=85:15の混合溶液
移動相流量:1ml/min
注入量:20μl
検出:UV検出器265nm
(vii)水分量の測定
タイトランド851型(メトローム・ジャパン製)を用いてカールフィッシャー電量滴定法により、油脂組成物の水分量を測定した。
(Vi) Quantitative determination of ascorbyl palmitate 0.5 g of ascorbic acid and 20 ml of 80% ethanol were added to 5 g of an oil and fat sample, and the mixture was stirred with a vortex mixer. After stationary separation, the ethanol layer was collected, 10 ml of 80% -ethanol was added to the residue, the same operation was performed, and the ethanol layer was collected. Again, 10 ml of 80% ethanol was added to the residue, and the same operation was performed. The obtained ethanol layers were combined, and the volume was adjusted to 50 ml with 0.05 N-acetic acid buffer (pH 4) (buffer A), followed by filtration through a glass filter. 2 ml of the filtrate was loaded onto a solid phase extraction column (Sep-Pak C18) previously treated with 10 ml of methanol and 5 ml of buffer solution (A), and 10 ml of distilled water and 5 ml of a mixed solution of buffer solution A: ethanol = 1: 1. After washing, elution was performed with 4 ml of methanol. 0.2 ml of 1% homocysteine aqueous solution was added to the eluate, treated at 40 ° C. for 15 minutes, and the volume was adjusted to 10 ml with 1% ascorbic acid aqueous solution and subjected to HPLC.
HPLC conditions:
Column: ODS-3 (4.6 ID × 250 mm), GL Sciences column temperature: 40 ° C.
Mobile phase: methanol / 0.05 M acetate buffer (pH 6.5) = 85: 15 mixed solution mobile phase flow rate: 1 ml / min
Injection volume: 20 μl
Detection: UV detector 265nm
(Vii) Measurement of moisture content The moisture content of the oil and fat composition was measured by a Karl Fischer coulometric titration method using Tightland 851 (manufactured by Metrohm Japan).

〔原料油脂(1)の調製〕
大豆油脂肪酸:菜種油脂肪酸=7:3(質量比)の混合脂肪酸100質量部とグリセリン15質量部とを混合し、酵素によりエステル化反応を行い、ジアシルグリセロール含有油脂を得た。得られたエステル化物から、蒸留により脂肪酸とモノアシルグリセロールを除去し、酸処理(10%クエン酸水溶液を2%添加)及び水洗、脱臭を行ったものを油脂(1)とした。グリセリド組成、脂肪酸組成を表1に示す。
[Preparation of raw oil and fat (1)]
A mixed fatty acid of soybean oil fatty acid: rapeseed oil fatty acid = 7: 3 (mass ratio) and 15 parts by mass of glycerin were mixed, and an esterification reaction was performed with an enzyme to obtain a diacylglycerol-containing fat. Fatty acid and monoacylglycerol were removed from the resulting esterified product by distillation, acid-treated (2% of 10% aqueous citric acid solution was added), washed with water, and deodorized to obtain oil (1). Table 1 shows the glyceride composition and the fatty acid composition.

菜種油(日清オイリオグループ(株)社製)を原料油脂(2)とし、グリセリン脂肪酸モノエステル(O−95R、花王(株)製)を原料油脂(3)とした。原料油脂(2)および(3)のグリセリド組成、脂肪酸組成を表1に示す。   Rapeseed oil (manufactured by Nisshin Oillio Group Co., Ltd.) was used as raw material fat (2), and glycerin fatty acid monoester (O-95R, manufactured by Kao Corporation) was used as raw material fat (3). Table 1 shows the glyceride composition and fatty acid composition of the raw oils and fats (2) and (3).

Figure 0005717356
Figure 0005717356

〔油脂A〜Gの調製〕
原料油脂(1)〜(3)を表2に示した質量比で混合して油脂A〜Gを調製した。油脂A〜Gのグリセリド組成、水酸基価を表2に示す。
[Preparation of fats and oils A to G]
The fats and oils A to G were prepared by mixing the raw fats and oils (1) to (3) at a mass ratio shown in Table 2. Table 2 shows the glyceride composition and the hydroxyl value of the fats and oils A to G.

Figure 0005717356
Figure 0005717356

〔溶解性試験〕
加温・攪拌後の油脂組成物を室温に24時間放置した後の状態を観察し、以下に示す判定基準に従って、溶解性を評価した。
○:透明に溶解している
×:濁り、溶け残りがある
[Solubility test]
The state after leaving the oil / fat composition after heating and stirring at room temperature for 24 hours was observed, and the solubility was evaluated according to the following criteria.
○: Dissolved transparently ×: Turbid and undissolved

〔官能評価〕
専門パネルにより油脂組成物1〜2gを生食し、以下に示す判定基準に従って、苦味を評価した。
3:苦い
2:やや苦い
1:苦くない
〔sensory evaluation〕
The fat and oil compositions 1 to 2 g were eaten with a specialized panel, and the bitterness was evaluated according to the following criteria.
3: Bitter 2: Slightly bitter 1: Not bitter

実施例1
油脂A〜Gに対し、表3及び4に示した質量比でビスベンチアミンジスルフィド(田辺三菱製薬製)をそれぞれ添加し、80℃の湯浴中にて2時間の加温・攪拌を行うことにより油脂組成物1〜24を調製した。分析値を表3及び4に示す。
Example 1
Add bisbenchamine disulfide (manufactured by Mitsubishi Tanabe Seiyaku) to the fats and oils A to G in the mass ratios shown in Tables 3 and 4, and perform heating and stirring for 2 hours in an 80 ° C. hot water bath. Thus, oil and fat compositions 1 to 24 were prepared. Analytical values are shown in Tables 3 and 4.

次に、各油脂組成物を用いて上記の溶解性試験、苦味の官能評価を行った。結果を表3及び4に示す。   Next, the above-described solubility test and bitter sensory evaluation were performed using each oil and fat composition. The results are shown in Tables 3 and 4.

Figure 0005717356
Figure 0005717356

Figure 0005717356
Figure 0005717356

表3及び4から分かるように、本発明の油脂組成物は、ビタミンB1誘導体を高濃度に溶解して含有することができ、且つ苦味の少ないものであった。油脂組成物15〜24では未溶解のビタミンB1誘導体が観察された。
さらに、油脂組成物2、4、6、7、9、11、13、14は、ビタミンB1誘導体由来の苦味がさらに抑制され、食用油として好ましいものであった。
As can be seen from Tables 3 and 4, the oil and fat composition of the present invention was able to contain the vitamin B1 derivative dissolved at a high concentration and had little bitterness. In oil composition 15-24, undissolved vitamin B1 derivative was observed.
Furthermore, the fat and oil compositions 2, 4, 6, 7, 9, 11, 13, and 14 were preferable as edible oils because the bitterness derived from the vitamin B1 derivative was further suppressed.

実施例2
油脂C又はGに対し、表5に示した質量比でビスベンチアミンジスルフィド(田辺三菱製薬製)、及びL−アスコルビン酸パルミテート(DSMニュートリション製)もしくはニコチン酸アミド(シグマ・アルドリッチ製)を添加し、80℃の湯浴中にて2時間の加温・攪拌を行うことにより油脂組成物25〜30を調製した。分析値を表5に示す。
Example 2
Add bisbenchamine disulfide (manufactured by Mitsubishi Tanabe Pharma Corporation) and L-ascorbyl palmitate (manufactured by DSM Nutrition) or nicotinamide (manufactured by Sigma-Aldrich) at a mass ratio shown in Table 5 to fat C or G. The oil and fat compositions 25-30 were prepared by heating and stirring for 2 hours in a 80 degreeC hot water bath. The analytical values are shown in Table 5.

次に、各油脂組成物を用いて、上記と同様に溶解性試験、苦味の官能評価を行った。結果を表5に示す。   Next, using each oil and fat composition, a solubility test and a bitter taste sensory evaluation were performed in the same manner as described above. The results are shown in Table 5.

Figure 0005717356
Figure 0005717356

表5から分かるように、本発明の油脂組成物はビタミンB1誘導体に加え、さらにアスコルビン酸パルミテート又はニコチン酸アミドを高濃度に溶解して含有することができ、且つ苦味の少ないものであった。   As can be seen from Table 5, the oil-and-fat composition of the present invention can contain ascorbyl palmitate or nicotinamide at a high concentration in addition to the vitamin B1 derivative, and has little bitterness.

Claims (5)

ビタミンB1誘導体又はその塩をチアミン換算で44〜8,000ppm含有し、水酸基価が9〜100mg−KOH/gであり、油脂を構成する脂肪酸の80〜100質量%が不飽和脂肪酸である油脂組成物であって、ビタミンB1誘導体又はその塩のチアミン換算における含有量C(ppm)と水酸基価X(mg−KOH/g)が次式(1)の関係を満たす油脂組成物。
(数1)
[Ln(C/143)]/X≦0.044 (Ln:自然対数) (1)
Vitamin B1 derivative or a salt thereof contained 44~8,000ppm with thiamine terms, hydroxyl value Ri 9~100mg-KOH / g der, 80 to 100 wt% of the fatty acid constituting the fat or oil is Ru unsaturated fatty der An oil / fat composition, wherein the content C (ppm) of the vitamin B1 derivative or salt thereof in terms of thiamine and the hydroxyl value X (mg-KOH / g) satisfy the relationship of the following formula (1).
(Equation 1)
[Ln (C / 143)] / X ≦ 0.044 (Ln: natural logarithm) (1)
ビタミンB1誘導体又はその塩のチアミン換算における含有量C(ppm)と水酸基価X(mg−KOH/g)が次式(2)の関係を満たす請求項1記載の油脂組成物。
(数2)
[Ln(C/82)]/X≦0.04(Ln:自然対数) (2)
The fat and oil composition according to claim 1, wherein the content C (ppm) of the vitamin B1 derivative or a salt thereof in terms of thiamine and the hydroxyl value X (mg-KOH / g) satisfy the relationship of the following formula (2).
(Equation 2)
[Ln (C / 82)] / X ≦ 0.04 (Ln: natural logarithm) (2)
ビタミンB1誘導体がビスベンチアミンジスルフィドである請求項1又は2記載の油脂組成物。   The fat and oil composition according to claim 1 or 2, wherein the vitamin B1 derivative is bisbenchamine disulfide. さらに、ビタミンCもしくはその誘導体又はニコチン酸アミドを含有する請求項1〜3のいずれか1項記載の油脂組成物。   Furthermore, the fats and oils composition of any one of Claims 1-3 containing vitamin C or its derivative (s), or nicotinic acid amide. 食用油である請求項1〜4のいずれか1項記載の油脂組成物。   It is an edible oil, The oil-fat composition of any one of Claims 1-4.
JP2010113906A 2010-04-08 2010-05-18 Oil composition containing vitamin B1 Active JP5717356B2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2010113906A JP5717356B2 (en) 2010-05-18 2010-05-18 Oil composition containing vitamin B1
MYPI2012004471A MY158524A (en) 2010-04-08 2011-04-07 Fat or oil composition
BR112012025757-9A BR112012025757B1 (en) 2010-04-08 2011-04-07 COMPOSITION OF OIL OR FAT, METHOD FOR ELIMINATING A BITTER LEVEL OF A VITAMIN B1 DERIVATIVE, A SALT OF THE SAME OR NICOTINAMIDE AND USE OF THAT COMPOSITION
KR1020127025948A KR101830450B1 (en) 2010-04-08 2011-04-07 Fator oil composition
US13/639,930 US20130040968A1 (en) 2010-04-08 2011-04-07 Fat or oil composition
PCT/JP2011/058817 WO2011126075A1 (en) 2010-04-08 2011-04-07 Fat or oil composition
EP11765975.5A EP2556751B1 (en) 2010-04-08 2011-04-07 Fat or oil composition
CN201180018043.7A CN102834019B (en) 2010-04-08 2011-04-07 Oil-and-fat composition
RU2012147462/13A RU2550024C2 (en) 2010-04-08 2011-04-07 Fat or oil composition
TW100112313A TWI532434B (en) 2010-04-08 2011-04-08 Grease composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010113906A JP5717356B2 (en) 2010-05-18 2010-05-18 Oil composition containing vitamin B1

Publications (2)

Publication Number Publication Date
JP2011239714A JP2011239714A (en) 2011-12-01
JP5717356B2 true JP5717356B2 (en) 2015-05-13

Family

ID=45407039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010113906A Active JP5717356B2 (en) 2010-04-08 2010-05-18 Oil composition containing vitamin B1

Country Status (1)

Country Link
JP (1) JP5717356B2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4234888B2 (en) * 1999-09-22 2009-03-04 花王株式会社 Antihypertensive agent
JP4381037B2 (en) * 2003-06-04 2009-12-09 花王株式会社 Oil composition
JP2008069184A (en) * 2005-02-21 2008-03-27 Kao Corp Oil-and-fat composition

Also Published As

Publication number Publication date
JP2011239714A (en) 2011-12-01

Similar Documents

Publication Publication Date Title
JP5636398B2 (en) Oil composition
CA2382223C (en) Fat or oil composition
JP4381037B2 (en) Oil composition
US8853192B2 (en) Fat or oil composition
EP1544281B1 (en) Fat composition
JP5100974B2 (en) Oil composition
JP2008069184A (en) Oil-and-fat composition
JP5039291B2 (en) Oil composition
JP5717356B2 (en) Oil composition containing vitamin B1
JP5808130B2 (en) Nicotinamide-containing oil and fat composition
WO2013027727A1 (en) Oil/fat composition
EP2556751B1 (en) Fat or oil composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140925

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150317

R151 Written notification of patent or utility model registration

Ref document number: 5717356

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250